Cvs Health dividend – CVS Health Increases Quarterly Dividend by 10%, Yield Reaches 2.4%

Trending News ☀️

CVS ($NYSE:CVS) Health is one of the largest pharmacy health care companies in the United States. CVS also provides a range of healthcare services, including MinuteClinic walk-in clinics, specialty pharmacy, infusion services, and long-term care programs. The company recently announced an increase in its dividend of 10%, raising its quarterly dividend to $0.605 per share. The dividend is payable on February 1 to shareholders of record as of January 20, with the ex-dividend date on January 19. This dividend increase brings the forward yield of CVS Health to 2.4%. CVS has a long history of increasing its dividend payments, with a five-year average annual growth rate of 10%.

In addition, CVS Health has a strong balance sheet and cash flow, making it well positioned to continue paying dividends in the future. CVS Health is a strong investment for those looking for a reliable source of income. With a forward dividend yield of 2.4% and a five-year average annual growth rate of 10%, CVS Health is an attractive option for dividend investors. In addition, CVS’s strong balance sheet and cash flow make it a good option for those looking for a reliable source of income.

Dividends – Cvs Health dividend

CVS Health recently announced an increase in their quarterly dividend for the 2022 fiscal year third quarter. The dividend per share will be 2.15 USD, a 10% increase from the 2.0 USD issued in both 2020 and 2021. This dividend yield puts CVS Health at a three-year average dividend yield of 2.65%, with the yields from 2020 to 2022 coming in at 3.1%, 2.59%, and 2.27%, respectively. For those interested in dividend stocks, CVS Health may be worth considering. Their increased dividend yield is attractive to investors looking for steady income that can be reinvested or used as spending money. The company also provides a diverse portfolio of products and services, which makes it a great source of income for those with a diversified portfolio.

CVS Health’s dividend increase is also noteworthy because it comes at a time when many other companies are cutting their dividends due to the economic uncertainty caused by the pandemic. Overall, CVS Health’s dividend increase provides a great opportunity for investors looking for steady income. The company’s three-year average dividend yield of 2.65% is much higher than the current market average and is likely to attract investors looking for reliable long-term returns. For those who are interested in dividend stocks, CVS Health may be worth considering.

About the Company

Market Price

On Thursday, CVS Health announced that its board of directors had approved a 10% increase in the quarterly dividend, resulting in a yield of 2.4%. The news came as a surprise to investors, as CVS Health had previously only indicated that it would maintain the dividend. At the same time, the stock opened at $99.4 and closed at $97.6, down by 3.1% from its prior closing price of $100.7. This news was met with mixed reactions from investors. On one hand, many investors were pleased to receive the dividend hike as it provided an increased return on their investments. On the other hand, some investors were concerned about the drop in share price, which could be a sign of further problems for the company. The increased dividend should help to improve investor sentiment towards the company while also providing an additional source of income for shareholders. Overall, the news of the dividend increase is a positive development for CVS Health shareholders. The increased yield of 2.4% is higher than the industry average and may provide some support for the stock price in the near future.

However, investors should still remain aware of any potential risks associated with investing in CVS Health and should continue to monitor the company’s performance over time. Live Quote…

VI Analysis

CVS Health is a medium risk investment that should be considered when making long-term decisions. This is evidenced by the company’s fundamentals, which are analyzed through the VI App. The App provides a comprehensive assessment of CVS Health’s financial, business and non-financial risks. This includes evaluations of the company’s income sheet, balance sheet and non-financial risks. Furthermore, the app has flagged 3 risk warnings that must be taken into consideration before investing. The VI App provides a comprehensive, user-friendly platform for investors that can help them make informed decisions about their investments. It takes into account a variety of factors such as market trends, competitor analysis, and financial reporting. Furthermore, the App provides data-driven insights into the company’s performance and financial health. This helps investors determine the best investment option for their needs. Overall, CVS Health is a medium risk investment that can be assessed through the VI App. The platform provides an in-depth evaluation of the company’s financial and business performance and can help investors make informed decisions. To gain access to the full assessment, it is recommended to become a registered user of the app. More…

VI Peers

The competition between CVS Health Corp and its competitors is fierce. Each company is striving to be the top provider of healthcare services and products. CVS Health Corp is the largest provider of pharmacy services in the United States. Marpai Inc is a close second. Molina Healthcare Inc and Humana Inc are also major competitors in the healthcare industry.

– Marpai Inc ($NASDAQ:MRAI)

Marpai Inc is a publicly traded company with a market capitalization of 20.89 million as of 2022. The company has a return on equity of -64.66%. Marpai Inc is engaged in the business of developing and marketing products and services for the energy industry. The company’s products and services include oil and gas exploration, production, and development; oilfield services; and petrochemical refining.

– Molina Healthcare Inc ($NYSE:MOH)

Molina Healthcare Inc is a health care company that provides Medicaid-related solutions for low-income families and individuals. As of 2022, the company had a market capitalization of 20.52 billion dollars and a return on equity of 24.89%. The company’s main business is providing managed care services under the Medicaid and Medicare programs. In addition to this, the company also provides other health services such as behavioral health, long-term care, and pharmacy services.

– Humana Inc ($NYSE:HUM)

Humana Inc is a healthcare company that offers a wide range of health and wellness products and services. The company has a market cap of 63.3B as of 2022 and a return on equity of 17.4%. Humana’s products and services include medical and prescription drug coverage, dental and vision coverage, and wellness and fitness programs. The company also offers a variety of health and wellness products and services for individuals, families, and businesses.

Summary

Investing in CVS Health can be a smart move for any investor looking to diversify their portfolio and gain exposure to a wide variety of sectors. With its strong presence in the retail and health care industries, CVS Health offers investors the opportunity to gain exposure to a range of areas.

In addition, CVS Health has made several strategic moves in recent years, such as acquiring Aetna, that have enabled it to expand its reach and offerings. The company currently offers investors a 2.4% dividend yield, which is attractive for those looking for income from their investments. Furthermore, CVS Health has a track record of increasing its dividend on a regular basis, and this most recent 10% increase is a testament to their commitment to shareholders. The company also has a strong balance sheet and solid financials, which can provide investors with confidence that their investments are safe and will perform well in the long-term. In addition, CVS Health is well-positioned to benefit from the growing demand for health care services in the United States and abroad. This is due to its presence in retail, specialty pharmacy, and mail order services.

Additionally, CVS Health has a wide range of products and services that can be leveraged by investors for long-term growth. These include the retail pharmacy business, MinuteClinic walk-in clinics, and the OptumRx specialty pharmacy business. As consumers continue to prioritize their health and wellness, CVS Health’s offerings should be well-positioned to capitalize on this trend. Overall, investing in CVS Health can be an attractive option for investors looking to diversify their portfolio and gain exposure to a broad range of sectors. With its strong financials, robust dividend yield, and wide range of offerings, CVS Health can provide investors with the potential for long-term growth and stability.